Surgical robot corporation Roen Surgical announced on the 7th that it has signed a licensing agreement for the Jamenix kidney stone surgical robot with a medical device specialist corporation in Indonesia.
This agreement includes the exclusive distribution rights for Jamenix throughout Indonesia, with a contract period of three years. PT Hospi Medik Indonesia, which signed the contract, is a subsidiary of Surgika Alkesindo, the largest medical device distribution company in Indonesia. The two companies specialize in distributing various medical equipment, including surgical equipment, medical imaging equipment, and radiation and medical devices.
After completing the licensing registration of Jamenix with the Indonesian Food and Drug Administration in the first half of this year, full-scale exports will begin in the second half. Jamenix is expected to be supplied to hospitals in Indonesia through PT Hospi Medik and Surgika Alkesindo.
Indonesia has a kidney stone prevalence rate of 0.6%, which is high compared to the Southeast Asian average. This is due to its geographical characteristics, which consist of many islands with high salinity and calcium content in drinking water. The company anticipates that the introduction of the AI-based Jamenix kidney stone removal robot will bring significant changes.
Jamenix consists of a flexible endoscope robot and a master console that operates it remotely. Jamenix's flexible endoscope is 2.8mm in size and removes stones repeatedly by passing through the urethra and ureter without incisions. As the doctor controls it from the master console, the flexible endoscope robot enters the patient's body to perform the surgery.
The features of Jamenix include precise and stable control technology and various AI functions, allowing for increased stone fragmentation and removal rates compared to existing surgical methods. It compensates for stone movement caused by the patient’s breathing with lasers, enhancing safety through precise laser irradiation and accurate stone fragmentation while reducing laser exposure time. Jamenix also includes AI that checks whether a stone can pass through the ureter. Large stones are shattered with lasers and removed without damaging the ureter.
Starting with the Indonesia contract, Roen Surgical plans to expand distribution into other Asian markets, including Thailand and Taiwan. CEO Kwon Dong-soo said, “We will strive to help more patients with intractable kidney stones through the full-scale distribution of Jamenix, starting with the Asian market.”